Name |
PI-103, Free Base
|
Supplier |
Biorbyt
|
Catalog |
orb153627
|
Prices |
$264.00, $323.00, $357.00, $553.00, $867.00, $1,267.00, $1,377.00
|
Sizes |
5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 250 mg
|
Cas Number |
[371935-74-9]
|
Pubchem |
9884685
|
Chemical Name |
3-(4-morpholin-4-ylpyrido[2,3]furo[2,4-b]pyrimidin-2-yl)phenol
|
Formula |
C19H16N4O3
|
Molecular Weight |
348.36 g/mol
|
Purity |
>99% pure
|
Description |
PI-103 is acts as a dual inhibitor of class IA phosphatidylinositide 3-kinase (PI3K) and mTOR. PIP3 activates Akt and mTOR, and plays important roles in cell growth and survival. PI-103 was mainly cytostatic for human leukemic cell lines and induced cell cycle arrest in the G1 phase. PI-103 inhibited endothelial cell proliferation and survival in vitro and tumor growth in vivo possibly by blocking activation of both PI3K and mTOR in vGPCR-expressing endothelial cells. PI-103 has been seen to have nominal effects inhibiting basal Na+ transport, but is very effective in abolishing insulin-induced Na+ absorption in the nephron.
|
Supplier Page |
Shop
|